Science

Fitbit conducts large scale study to identify atrial fibrillation using its wearable tech

Hemani Sheth Mumbai | Updated on May 08, 2020 Published on May 08, 2020

Fitbit on Thursday launched its Fitbit Heart Study, a large-scale, virtual study to validate the use of its wearable technology to identify heart activity suggestive of atrial fibrillation (AFib).

AFib is one of the most common forms of heart rhythm irregularities. The study will use Fitbit’s wearable tech to detect irregular heart rhythm suggestive of the condition,

“The study is part of the company’s broader strategy to make easy-to-use tools that accelerate detection of a range of conditions more accessible. The Fitbit Heart Study aims to enrol hundreds of thousands of people, and its results will support the company’s regulatory submissions globally,” Fitbit said in an official statement.

Until recently, tools for detecting AFib had several limitations and were only accessible if you visited a doctor,” said Steven Lubitz, M.D., M.P.H, principal investigator of the Fitbit Heart Study, a cardiologist at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School. “My hope is that advancing research on innovative and accessible technology, like Fitbit devices, will lead to more tools that help improve health outcomes and reduce the impact of AFib on a large scale.”

How it works

Fitbit wearables have 24/7 heart rate tracking. The feature can allow the tool to record heart rhythm and detect irregularities that may lead to AFib.

“The optimal way to identify irregular rhythm through heart rate tracking technology is to screen when the body is at rest, making assessment overnight, while people sleep, ideal for detection,” the company explained.

“The Fitbit Heart Study advances our heart health efforts. Long-term passive heart rhythm assessment with our wide range of affordable devices powered by 24/7 heart rate tracking technology has the potential to improve earlier identification of AFib, which is a key to reducing the risk of a life-threatening event like a stroke,” said Eric Friedman, Fitbit co-founder and CTO.

Fitbit’s devices use photoplethysmography (PPG) technology to track heart rate. The devices measure the rate of blood flow from a user’s wrist.

This data will then be used to determine a user’s heart rhythm. Fitbit’s algorithm will then analyze this as part of the Fitbit Heart Study. Volunteers participating in the study will then be notified if an irregular heart rhythm is detected and will connect with a doctor for a virtual appointment at no cost to get more information and may receive an electrocardiogram (ECG) patch in the mail at no cost to confirm the notification.

The company is also developing PPG and ECG tools that could offer both long-term assessment and spot-check AFib detection.

“The Company has completed a pivotal clinical trial of its new ECG feature and plans to seek review by the U.S. Food and Drug Administration (FDA) and global regulatory authorities,” Fitbit said.

The Fitbit heart study is open for users in the United States aged 22 years and older with a current Fitbit device that tracks heart rate. This includes Fitbit Ionic, Fitbit Versa family of smartwatches, Fitbit Charge 3, Fitbit Charge 4, and Fitbit Inspire HR. Users can enrol from the company’s website.

Published on May 08, 2020

A letter from the Editor


Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Sincerely,

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.